Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Japan To Support Trials Of 50 Drugs For Critical Diseases

This article was originally published in PharmAsia News

Executive Summary

Japan's health ministry says it will provide more than $791 million in support for clinical trials by the nation's drug makers to test 50 selected treatments for incurable and critical ailments. The Ministry of Health, Labor and Welfare said it invites various institutions, organizations and patient groups to recommend the treatments to be covered over a three-year period. The ministry said it also would expedite approvals for such drugs by cutting in half the process for reviewing them, now a one-year process. The drugs to be covered would be limited to those already approved in France, Germany, the United Kingdom and the United States. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC072043

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel